For example, are you seeing lower prices on semaglutide-type peptides, or across the board? Curious whether this is actual supplier pricing or just temporary sales.
a price drop can be real and still mean nothing if suppliers are just racing to the bottom—would want to see whether it’s across the market or just headline pricing.
Raw-material costs and expanded synthesis capacity can absolutely push peptide prices down—especially on the bulk side. The funny part is retail vendors seem to discover “market corrections” several months later, usually after quietly keeping the old margin. So no, probably not dreaming.
Could the apparent drop be coming more from increased manufacturing capacity than weaker demand? I’m curious whether people are seeing broad price cuts or just a few vendors undercutting everyone else.
like the peptide market finally hit clearance season. the idea of prices actually dropping across the board is the interesting part—are you seeing that from vendors, or just a few outliers?
Discussion 11